• ART, when taken throughout pregnancy, delivery and breastfeeding, can reduce the risk of HIV transmission to an infant to less than 5%. Women who test HIV-positive during their prenatal visits at EGPAF-supported sites are immediately linked to lifelong ART and counseled on benefits of enrollment and retention on treatment.

    readMore